<DOC>
	<DOCNO>NCT00411944</DOCNO>
	<brief_summary>An evaluation effect genetically determine variant metabolize transport protein involve disposition immunosuppressive drug tacrolimus renal transplant recipient . In five year follow-up study tacrolimus dose-corrected exposure change significantly effect ( ) single nucleotide polymorphism CYP3A4/CYP3A5 MDR1 gene latter assess study .</brief_summary>
	<brief_title>Long-Term Pharmacokinetics Tacrolimus Renal Recipients</brief_title>
	<detailed_description>A 5-year pharmacokinetic follow-up study 95 renal allograft recipient assess tacrolimus exposure use repeat abbreviated Area-Under-the-Concentration-time ( AUC ) curve measurement regular time point graft . The effect CYP3A5*1 , CYP3A4*1B , MDR1 G2677T/A C3435T single nucleotide polymorphisms evolution tacrolimus disposition study 5 year order clarify interrelationship CYP3A5 , CYP3A4 MDR1 genotype , time-dependent exposure tacrolimus-related toxicity .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Primary secondary single kidney transplantation Age old 18 yr Combined organ transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>tacrolimus pharmacokinetics</keyword>
	<keyword>CYP3A4 - CYP3A5</keyword>
	<keyword>P-glycoprotein</keyword>
	<keyword>single nucleotide polymorphism</keyword>
	<keyword>renal transplantation</keyword>
	<keyword>calcineurin-inhibitor-associated nephrotoxicity</keyword>
</DOC>